Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2009
11/26/2009WO2009143211A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
11/26/2009WO2009143078A2 Methods of treating brain cancer using hexose compounds
11/26/2009WO2009143064A2 Rice bran extracts for inflammation and methods of use thereof
11/26/2009WO2009143051A1 Substituted imidazopyr-and imidazotri-azines
11/26/2009WO2009143024A2 Compounds and methods for kinase modulation, and indications therefor
11/26/2009WO2009143018A2 Compounds and methods for kinase modulation, and indications therefor
11/26/2009WO2009142893A2 Methods and compositions for the delivery of bioactive compounds
11/26/2009WO2009142892A1 Methods and compositions comprising novel cationic lipids
11/26/2009WO2009142754A1 Dendritic conjugates and methods of use
11/26/2009WO2009142602A1 Nucleic acid molecule and method of targeting gene expression to gliomas
11/26/2009WO2009142328A1 Camptothecin polymer derivative and uses of the same
11/26/2009WO2009142326A1 Docetaxel polymer derivative, method for producing same and use of same
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009142271A1 Cancer stem cell having high level of sld5 expression therein
11/26/2009WO2009142186A1 Cytotoxic composition
11/26/2009WO2009141687A1 New optically pure compounds for improved therapeutic efficiency
11/26/2009WO2009141659A1 Depsipeptides and their therapeutic use
11/26/2009WO2009141658A1 Depsipeptides and their therapeutic use
11/26/2009WO2009141657A1 Depsipeptides and their therapeutic use
11/26/2009WO2009141645A1 Cancer therapy
11/26/2009WO2009141575A1 Inhibitors of plk
11/26/2009WO2009141386A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009WO2009141090A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
11/26/2009WO2009141079A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
11/26/2009WO2009140928A1 Dihydroindolinone derivatives
11/26/2009WO2009140887A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
11/26/2009WO2009140886A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
11/26/2009WO2009140863A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof
11/26/2009WO2009140755A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009WO2009140754A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009WO2009116764A3 Cell migration, cell infiltration, or neovascularization inhibitor through degradation of function of ptk7 protein
11/26/2009WO2009115562A3 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
11/26/2009WO2009114658A3 Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
11/26/2009WO2009111028A8 Aurora kinase inhibitors
11/26/2009WO2009108868A3 Radiolabeled hedgehog derivatives for imaging and therapy
11/26/2009WO2009098690A3 Novel fer -like protein, pharmaceutical compositions containing it and method for its use
11/26/2009WO2009095916A3 Cd14 and peptides thereof for protection of cells against cell death
11/26/2009WO2009080722A3 Carboxylic derivatives for use in the treatment of cancer
11/26/2009WO2009073533A3 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use
11/26/2009WO2009066182A4 Method of treating cancer
11/26/2009WO2009050506A3 Combination 059
11/26/2009WO2009043458A3 Use of oxytocin to treat many diseases
11/26/2009WO2009043457A3 Use of human hemokinin-1 and optionally oxytocin to treat diseases involving excessive angiogenesis
11/26/2009WO2009040024A3 Use of bim-23127 and optionally urodilatin as therapeutic agents eg for the treatment of m. tuberculosis infections
11/26/2009WO2009039981A3 Use of (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009039980A3 Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009033820A3 Use of saralasin and carbetocin in combination to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033783A3 Use of carbetocin to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033782A3 Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis
11/26/2009WO2009007677A3 Dsb repair- inhibitors as anti-tumour agents
11/26/2009WO2008122858A8 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
11/26/2009US20090293138 Animal models carrying tumors expressing human prostate cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics
11/26/2009US20090292113 Recombinant soluble Fc receptors
11/26/2009US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/26/2009US20090292019 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
11/26/2009US20090292017 Therapeutic compositions
11/26/2009US20090292014 Benzofuran derivatives useful for treating hyper-proliferative disorders
11/26/2009US20090292008 Compositions and Methods for Treatment of Prostate and Other Cancers
11/26/2009US20090292005 L- alpha -dioleoyl phosphatidyl{14-N-(1-deoxylactito-1-yl)amino-3,6,9,12-tetraoxa}tetra decanol; 2-O-{2-N-(1-deoxylactito-1-yl)aminoethyl} carbamoyl-1,3-O-dioleoyl glycerol; galactose, a suitable spacer and a certain lipid, a drug carrier; efficiently transferred into the liver
11/26/2009US20090292003 Cell penetrating peptides for intracellular delivery of molecules
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291992 Androgen receptor-ablative agents
11/26/2009US20090291984 Substituted pyrazoles, compositions containing these, method of production and use
11/26/2009US20090291978 Enzyme Inhibitors
11/26/2009US20090291972 Compositions and Methods Relating to Nuclear Hormone and Steroid Hormone Receptors Including Inhibitors of Estrogen Receptor Alpha-mediated Gene Expression and Inhibition of Breast Cancer
11/26/2009US20090291971 Heteroaryl ethers and processes for their preparation
11/26/2009US20090291967 Small molecule modulators of cell adhesion
11/26/2009US20090291965 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs
11/26/2009US20090291961 Combination of an mek inhibitor and the src kinase inhibitor azd0530 for use in the treatment of cancer
11/26/2009US20090291956 SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
11/26/2009US20090291951 Novel Cyclic Compound Having Pyrimidinylalkylthio Group
11/26/2009US20090291943 Process for preparing diaminophenothiazinium compounds
11/26/2009US20090291932 Pharmaceutical solid state forms
11/26/2009US20090291925 Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
11/26/2009US20090291924 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
11/26/2009US20090291923 Trioxane dimers having high anticancer and long-lasting antimalarial activities
11/26/2009US20090291916 Trihydroxy Polyunsaturated Eicosanoid
11/26/2009US20090291904 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
11/26/2009US20090291889 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
11/26/2009US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009US20090291429 Substances causing differentiation
11/26/2009US20090291144 Therapeutic and Prophylactic Compositions Including Catalytic Biomimetic Solids and Methods to Prepare and Use Them
11/26/2009US20090291142 Nanoparticulate bicalutamide formulations
11/26/2009US20090291131 Silencing of polo-like kinase expression using interfering rna
11/26/2009US20090291128 Transdermal delivery of cannabinoids
11/26/2009US20090291098 Immunogenic LHRH compositions and methods relating thereto
11/26/2009US20090291093 Immunoconjugates with an Intracellularly-Cleavable Linkage
11/26/2009US20090291088 Therapeutic combinations of anti-igf-1r antibodies and other compounds
11/26/2009US20090291087 Modulating angiogenesis
11/26/2009US20090291085 Human estrogen receptor specific immunoglobulin for use in treatment and prevention of cell proliferative disorders
11/26/2009US20090291083 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same
11/26/2009US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
11/26/2009US20090291075 Binding agents and their use in targeting tumor cells
11/26/2009US20090291074 Mutations in oas1 genes
11/26/2009US20090291049 Targeted delivery to human diseases and disorders
11/26/2009US20090291047 Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
11/26/2009CA2761971A1 Rice bran extracts for inflammation and methods of use thereof
11/26/2009CA2725278A1 Depsipeptides and their therapeutic use
11/26/2009CA2725185A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009CA2725001A1 Dihydroindolone derivatives
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 2211